Anaraki FakhroSadat, Alemrajabi Mahdi, Shekouhi Ramin, Sohooli Maryam, Sabz Seyed-Ali
Department of General Surgery, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Firoozgar Clinical Research Development Center (FCRDC), Iran University of Medical Sciences, Tehran, Iran.
Surg Pract Sci. 2023 Jun 23;14:100191. doi: 10.1016/j.sipas.2023.100191. eCollection 2023 Sep.
Abdominoperineal resection (APR) is considered the gold standard surgical treatment for ultra-low rectal cancer. Anus-preserving alternative procedures have been tested to avoid the need for a permanent colostomy. The present study compares the functional and oncological outcomes of the traditional APR methods with inter-sphincteric resection (ISR).
Sixty patients with ultra-low rectal cancers that underwent tumor resection using the ISR and APR methods were compared retrospectively. Patients' demographic information as well as tumor characteristics were evaluated. All patients were followed after the operation every three months for two years, and then every six months for at least three years.
Thirty-four (56.6%) patients were male, and 26 (43.3%) were females, which showed no statistical significance between the two groups. The mean tumor distance from the anal verge in the APR group was 5.11±0.06 cm and in the ISR group was 5.22±1.1 cm. In the APR group, 9 (30%) patients developed primary tumor recurrence, while in the ISR group, 10 (33.3%) patients had relapses. The observed difference was not statistically significant. However, the study showed that patients with a T stage of T2 or higher had a higher probability of tumor recurrence.
There is no significant difference in the efficacy of the ISR method compared with the conventional APR for the treatment of ultra-low rectal cancer.
腹会阴联合切除术(APR)被认为是超低位直肠癌的金标准手术治疗方法。已对保留肛门的替代手术进行了测试,以避免永久性结肠造口的需要。本研究比较了传统APR方法与括约肌间切除术(ISR)的功能和肿瘤学结果。
回顾性比较了60例采用ISR和APR方法进行肿瘤切除的超低位直肠癌患者。评估了患者的人口统计学信息以及肿瘤特征。所有患者术后每三个月随访两年,然后每六个月随访至少三年。
34例(56.6%)患者为男性,26例(43.3%)为女性,两组间无统计学差异。APR组肿瘤距肛缘的平均距离为5.11±0.06 cm,ISR组为5.22±1.1 cm。APR组9例(30%)患者出现原发肿瘤复发,而ISR组10例(33.3%)患者复发。观察到的差异无统计学意义。然而,研究表明,T2期或更高分期的患者肿瘤复发概率更高。
与传统APR相比,ISR方法治疗超低位直肠癌的疗效无显著差异。